75
Participants
Start Date
September 30, 2008
Primary Completion Date
April 30, 2011
Study Completion Date
April 30, 2011
vildagliptin
50mg qd
sitagliptin
25mg qd
SUNY - Upstate Medical University, Syracuse
HRRG, Orchard Park
Renal Endocrine Associates, P. C., Pittsburgh
Lehigh Valley Hospital-Dept. of Medicine Research, Allentown
Thomas Jefferson University Hospital, Philadelphia
Joslin Diabetes Center at North Arundel Hospital, Glen Burnie
Clinical Research and Consulting Center, LLC, Fairfax
Nephrology Associates of Northern Virginia, Fairfax
Medical College of Virginia, Richmond
SC Nephrology and Hyptertension Center, Inc., Orangeburg
Sumter Medical Specialists, Sumter
Medical U of South Carolina, Charleston
Aiken Center for Clinical Research, Aiken
Atlanta Diabetes Associates, Atlanta
Emory Clinic, Atlanta
Jacksonville Center for Clinical Research, Jacksonville
University of Florida Shands Hospital, Gainesville
Osler Medical Clinical Research, Melbourne
Center for Diabetes & Endocrine Care, Hollywood
Larry Levinson, D.O., PA, Hollywood
Nephrology Associates of South Miami, Aventura
Tampa Bay Nephrology Associates, Tampa
University of South Alabama Medical Center, Mobile
Medical Nephrology Associates, Dyersburg
AM Diabetes and Endocrinology Center, Bartlett
Phillips Medical Services, PLLC, Jackson
Mississippi Medical Research, LLC, Picayune
The Ohio State University Medical Center, Columbus
University of Cincinnati, Cincinnati
Hightop Medical Research Center, Cincinnati
Genesys Integrated Group Practice, PC, Flint
Iowa Diabetes & Endocrinology Research Center PLC, Des Moines
University of Iowa, Iowa City
UW Health - West Clinic, Madison
Mayo Clinic Rochester, Rochester
Meritcare Medical Group, Fargo
Diabetes and Endocrinology Specialist, Inc, Chesterfield
Washington U School of Medicine, St Louis
Arms, Dodge, Robinson, Wilber & Crouch, Inc., Kansas City
Jefferson City Medical Group, Jefferson City
Cray Diabetes Education Center, Kansas City
Cotton-O'Neil Diabetes & Endocrinology Center, Topeka
Creighton Diabetes Center, Omaha
Creighton Nephrology, Omaha
Platte Valley Medical Group, Kearney
Egan Healthcare, Metairie
Crescent City Clinical Research Center, Metairie
Bruce Samuels LLC, Covington
Metabolic Center of Louisiana, Baton Rouge
Dolby Research, LLC, Baton Rouge
Arthritis and Diabetes Clinic, Monroe
Mary K. Richards, MD. PA, Little Rock
University of Arkanasas for Medical Sciences, Little Rock
Dallas Diabetes & Endocrine Center, Dallas
North Texas Endocrine Center, Dallas
Baylor College of Medicine, Houston
Renal Associates, P.A., San Antonio
Allied Institute of Medicine, San Antonio
Texas Tech University Health Sciences Center, El Paso
Western Nephrology & Metabolic Bone Disease PC, Westminster
Western Nephrology & Metabolic Bone Disease PC, Lakewood
Denver Nephrology PC, Denver
Boise Kidney & Hypertension Institiute, Meridian
Central Utah Clinic, American Fork
Anasazi Internal Medicine, Phoenix
Sonoran Health Specialists, Scottsdale
University of New Mexico Health Science Center, Albuquerque
Academic Medical Research Institute, Los Angeles
UCLA Medical Center, Los Angeles
Dr. Wei Feng, Pasadena
California Institute of Renal Research, San Diego
Burlingame
John Muir Clinical Research, Concord
Sierra Clinical Research - Orangevale, Roseville
University of Hawaii, Honolulu
Portland Hypertension and Nephrology, Oregon City
Willamette Valley Clinical Studies, Eugene
Washington State University at Spokane, Spokane
Baylor Clinic (BCM 621), Houston
Northern California Institute for Bone Health, Oakland
Hartford Hospital, Hartford
Northwest Louisiana Nephrology Research, Shreveport
Biolab Research, LLC, Rockville
Harvard University (Joslin Diabetes Center), Boston
UMDNJ-Robert Wood Johnson, New Brunswick
Downstate University of Brooklyn, Brooklyn
Medical College of Virginia, Richmond
Lead Sponsor
Novartis
INDUSTRY